Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insulin resistance. The objective of this study is to compare fasting glucose, fasting insulin concentrations and HOMA-IR in strength of association with incident cardiovascular disease. METHODS: We searched the PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect and Cochrane Library databases from inception to March, 2011, and screened reference lists. Cohort studies or nested case-control studies that investigated the association between fasting glucose, fasting insulin or HOMA-IR and incident cardiovascular disease, were eligible. Two investigators independently performed the article selection, data extraction and risk of bias assessment. Cardiovascular endpoints were coronary heart disease (CHD), stroke or combined cardiovascular disease. We used fixed and random-effect meta-analyses to calculate the pooled relative risk for CHD, stroke and combined cardiovascular disease, comparing high to low concentrations of glucose, insulin or HOMA-IR. Study heterogeneity was calculated with the I(2) statistic. To enable a comparison between cardiovascular disease risks for glucose, insulin and HOMA-IR, we calculated pooled relative risks per increase of one standard deviation. RESULTS: We included 65 studies (involving 516,325 participants) in this meta-analysis. In a random-effect meta-analysis the pooled relative risk of CHD (95% CI; I(2)) comparing high to low concentrations was 1.52 (1.31, 1.76; 62.4%) for glucose, 1.12 (0.92, 1.37; 41.0%) for insulin and 1.64 (1.35, 2.00; 0%) for HOMA-IR. The pooled relative risk of CHD per one standard deviation increase was 1.21 (1.13, 1.30; 64.9%) for glucose, 1.04 (0.96, 1.12; 43.0%) for insulin and 1.46 (1.26, 1.69; 0.0%) for HOMA-IR. CONCLUSIONS: The relative risk of cardiovascular disease was higher for an increase of one standard deviation in HOMA-IR compared to an increase of one standard deviation in fasting glucose or fasting insulin concentration. It may be useful to add HOMA-IR to a cardiovascular risk prediction model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both prediabetes and metabolic syndrome confer increased risk of T2D and CVD.802–804”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [803]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a meta-analysis of the association between Homeostasis Model Assessment Insulin Resistance (HOMA-IR) and cardiovascular events used dose-response modelling to estimate that the cardiovascular risk increased by 46% per one standard deviation increase in HOMA-IR [24].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In observational studies, a reduction in HOMA-IR was also associated with a reduction in CRP 81 and cardiovascular risk. 82”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 2×
“Finally, we only included studies that measured HOMA-IR, which is a surrogate measure of insulin resistance and mainly reflects hepatic insulin resistance [12].”
BackgroundMethodIDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Research works printed but not linked: 1
- Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Lippincott Williams & Wilkins. 112 p.
Cited by
Items 101–200 of 402
Yoon, J. S., Shim, Y. S., Lee, H. S., Hwang, I. T., & Hwang, J. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-03138-6 · Cited by 43
Zhang, Z., Zhao, L. Y., Lu, Y., Meng, X., & Zhou, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01205-8 · Cited by 48
“Elevated HOMA-IR has a significant association with risk of incident cardiovascular events, ischemic stroke and diabetes [48, 49].”
BackgroundYaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024) · Nutrients · doi:10.3390/nu16152441 · Cited by 48
“HOMA-IR is a clinical marker of insulin resistance that strongly correlates with atherosclerosis in patients with T2DM and metabolic syndrome [37,38].”
BackgroundSpence, J. D., Viscoli, C. M., Kernan, W. N., Young, L. H., Furie, K. L., DeFronzo, R. A., Abdul‐Ghani, M. A., Dandona, P., & Inzucchi, S. E. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14687 · Cited by 38
Adipose Tissue Dysfunction: Clinical Relevance and Diagnostic Possibilities
Schrover, I. M., Spiering, W., Leiner, T., & Visseren, F. L. J. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-103243 · Cited by 41
Colmorten, K. B., Nexøe, A. B., & Sørensen, G. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02264 · Cited by 35
Bazyar, H., Javid, A. Z., Masoudi, M. R., Haidari, F., Heidari, Z., Hajializadeh, S., Aghamohammadi, V., & Vajdi, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-59659-3 · Cited by 40
Guo, Z., Guo, X., Xu, H., Chu, H., Tian, Y., Wang, S., & Wang, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02492-y · Cited by 47
“Several prospective studies have demonstrated that both metabolic syndrome and Homeostatic Model Assessment for IR (HOMA-IR) are independent predictors of cardiovascular disease (CVD) [1–4].”
Kipp, Z. A., Badmus, O. O., Stec, D. E., Hall, B., & Hinds, T. D. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156081 · Cited by 37
van Son, J., Serlie, M. J. M., Ståhlman, M., Bäckhed, F., Nieuwdorp, M., & Aron‐Wisnewsky, J. (2021) · Nutrients · doi:10.3390/nu13082706 · Cited by 34
“However, insulin resistance in the absence of diabetes has also shown to be an independent risk factor for CVD [7,8].”
BackgroundBiomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition
Pokushalov, E., Ponomarenko, A., Shrainer, E., Kudlay, D. A., & Miller, R. (2024) · Nutrients · doi:10.3390/nu16234033 · Cited by 44
“Patients with high insulin may benefit from supplements that support glucose metabolism, such as alpha-lipoic acid and magnesium [64].”
Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans
Kim, K.-S., Lee, Y., Lee, I., Kim, D. J., Jacobs, D. R., & Lee, D. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu194 · Cited by 31
Wu, S., Liu, W., Ma, Q., Yu, W., Guo, Y., Zhao, Y., Shi, D., Liu, Y., Zhou, Z., Wang, J., et al. (2018) · Angiology · doi:10.1177/0003319718809931 · Cited by 31
“Previous clinical studies have confirmed the association between IR and CAD prevalence.(3,19) Consequent IVUS studies focused on its impact on coronary artery pathological changes.”
Diamond, D. M., O’Neill, B. J., & Volek, J. S. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000568 · Cited by 34
Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
Górna, I., Napierała, M., & Florek, E. (2020) · Toxics · doi:10.3390/toxics8040105 · Cited by 36
“It is known that elevated glucose and insulin levels as well as insulin resistance can contribute to the development of atherosclerosis also through dyslipidemia, hypertension and inflammatory condition [50].”
BackgroundCardiovascular Disease in Diabetes
Py, Z. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-3512-6 · Cited by 30
Kline, C. E., Hall, M. H., Buysse, D. J., Earnest, C. P., & Church, T. S. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0013 · Cited by 28
Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats
Mabuza, L. P., Gamede, M. W., Maikoo, S., Booysen, I. N., Ngubane, P. S., & Khathi, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s183811 · Cited by 31
“In addition, increased ROS production through advanced glycation end products (AGEs) which manifest subsequent endothelial dysfunction may elucidate the reduced coronary blood flow reserve and exacerbate hypertension.(23,27) During PD, hypertension may be present at the onset of the disease.”
BackgroundAtrial fibrillation in the cardiometabolic patient
Sensi, F. D., Costantino, S., Limbruno, U., & Paneni, F. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05882-2 · Cited by 30
Zhang, Y., Chu, C., Zhong, Z., Luo, Y., Ning, F.-F., & Guo, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1101952 · Cited by 33
Zou, J., Wang, Z., Qu, Q., & Wang, L. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.03.008 · Cited by 32
Howell, C. R., Zhang, L., Mehta, T. S., Wilkinson, L., Carson, A. P., Levitan, E. B., Cherrington, A., Yi, N., & Garvey, W. T. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100868 · Cited by 39
Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?
Cimmino, G., Natale, F., Alfieri, R., Cante, L. C., Covino, S., Franzese, R., Limatola, M., Marotta, L., Molinari, R., Mollo, N., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092353 · Cited by 38
“On this regard, HOMA index is a well-established marker of IR [135] with a defined prognostic value in CV patients [136] and it should be add to the current score for CV risk estimation.”
BackgroundHambly, R., Kearney, N., Hughes, R., Fletcher, J. M., & Kirby, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086969 · Cited by 32
“Insulin resistance, hormonal dysregulation, and obesity contribute to a proinflammatory state [16,17] and there is a strong correlation between the presence of insulin resistance and CV risk [91,92], as well as the risk of subsequent development of T2DM [93].”
BackgroundHellgren, M. I., Daka, B., Jansson, P., Lindblad, U., & Larsson, C. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314537917 · Cited by 29
“Likewise, several previous studies have identified insulin resistance as an important predictor of CVD.7 Although the mechanisms behind the findings are not fully understood, it is clear that the causes are multi-factorial.”
BackgroundInfluentialWhitney, D. G., Peterson, M. D., Devlin, M. J., Caird, M. S., Hurvitz, E. A., & Modlesky, C. M. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000981 · Cited by 29
Wang, Z., Wang, L., Fan, H., Lu, X. J., & Wang, T. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.09.021 · Cited by 28
Wang, H., He, S., Wang, J., An, Y., Wang, X., Li, G., & Gong, Q. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110199 · Cited by 25
Özkur, E., Erdem, Y., Altunay, İ. K., Demіr, D., Dolu, N. Ç., Serin, E., & Çerman, A. A. (2020) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2020.04.009 · Cited by 29
Binsch, C., Barbosa, D. M., Hansen-Dille, G., Hubert, M., Hodge, S. M., Kolasa, M., Jeruschke, K., Weiß, J., Springer, C. A., Gorreßen, S., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01746-2 · Cited by 30
“Background Type 2 diabetes mellitus (T2DM) constitutes a major risk factor for the development of cardiovascular disease (CVD) [1, 2].”
BackgroundInfluentialZhang, M., Guan, Q., Guo, Z., Guan, C., Jin, X., Dong, H., Tang, S., & Hou, H. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00380-6 · Cited by 28
“In this context, insulin resistance (IR), characterized by a pathophysiological dysfunction wherein tissue cells exist disordered insulin-mediated regulation of glucose metabolism, has been proposed as a promising marker in predicting metabolic disorders and CVD [20, 21].”
Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet
Diamond, D. M., Bikman, B. T., & Mason, P. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000764 · Cited by 27
A Mitochondrial Approach to Cardiovascular Risk and Disease
Veloso, C. D., Belew, G. D., Ferreira, L. L., Grilo, L. F., Jones, J. G., Portincasa, P., Sardão, V. A., & Oliveira, P. J. (2019) · Current Pharmaceutical Design · doi:10.2174/1389203720666190830163735 · Cited by 26
Sun, Y., Dinenno, F. A., Tang, P., & Kontaridis, M. I. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1445739 · Cited by 27
Dye, C. K., Corley, M. J., Li, D., Khadka, V. S., Mitchell, B. I., Sultana, R., Lum‐Jones, A., Shikuma, C. M., Ndhlovu, L. C., & Maunakea, A. K. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0694-1 · Cited by 23
Significance of Lipid Profile Parameters in Predicting Pre-Diabetes.
Jasim, O. H., Mahmood, M. M., & Ad'hiah, A. H. (2022) · PubMed · doi:10.22092/ari.2021.356465.1846 · Cited by 38
Associations of erythrocyte fatty acid patterns with insulin resistance
Bigornia, S., Lichtenstein, A. H., Harris, W. S., & Tucker, K. L. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.123604 · Cited by 24
Pavithran, N., Kumar, H., Menon, A. S., Pillai, G. K., Sundaram, K. R., & Ojo, O. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176232 · Cited by 23
“This investigation has drawn attention to other metabolic parameters that contribute to the development of CVD risks in patients with type 2 diabetes.”
BackgroundInfluentialOkuma, H., & Tsuchiya, K. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108699 · Cited by 24
Kim, K., Hong, S., Hwang, Y., Ahn, H. Y., & Park, C. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07681-4 · Cited by 22
“Several studies have shown that elevated insulin resistance is associated with an increased risk of cardiovascular mortality.(7,8) However, few studies have evaluated the association between insulin resistance and overall mortality.”
BackgroundThe influence of epigenetics and inflammation on cardiometabolic risks
Raghubeer, S. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.02.006 · Cited by 25
The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01180-2 · Cited by 27
“However, another similar study using the same PET tracers in cognitively unimpaired adults did not find that an interaction between FHS CVD risk and amyloid was related to tau [37].”
BackgroundInfluentialLertsakulbunlue, S., Mungthin, M., Rangsin, R., Kantiwong, A., & Sakboonyarat, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-40299-y · Cited by 22
“Insulin resistance (IR) was found to strongly correlate with an increased risk of developing CVD 7 .”
BackgroundKurl, S., Zaccardi, F., Onaemo, V. N., Jae, S. Y., Kauhanen, J., Ronkainen, K., & Laukkanen, J. A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0615-x · Cited by 24
Montalcini, T., Pujia, A., Donini, L. M., Frittitta, L., Galvano, F., Natali, A., Pironi, L., Porrini, M., Riso, P., Rivellese, A. A., et al. (2020) · Nutrients · doi:10.3390/nu12092662 · Cited by 24
“There is also a strong correlation between insulin resistance and the risk of developing CVD [79].”
BackgroundInfluentialMigraine: A disorder of metabolism?
Kokavec, A. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.10.029 · Cited by 27
“Insulin resistance is a known risk factor for hypertension [132], stroke [108], cardiovascular disease [73], metabolic syndrome [82] and migraine [179].”
BackgroundDiNicolantonio, J. J., & O’Keefe, J. H. (2017) · Open Heart · doi:10.1136/openhrt-2017-000729 · Cited by 30
Vargas‐Vázquez, A., Fermín‐Martínez, C. A., Antonio‐Villa, N. E., Fernández‐Chirino, L., Ramírez‐García, D., Dávila-López, G., Díaz-Sánchez, J. P., Aguilar-Salinas, C. A., Seiglie, J. A., & Bello‐Chavolla, O. Y. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117508 · Cited by 23
Bai, W., Chen, H., Wan, H., Ye, X., Ling, Y., Xu, J., Guo, X., & He, J. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02499-y · Cited by 23
“Identifying IR in individuals is clinically significance for the prevention of CVD development [28].”
How do high glycemic load diets influence coronary heart disease?
Mathews, M. J., Liebenberg, L., & Mathews, E. H. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0001-x · Cited by 26
Are insulin-resistance and oxidative stress cause or consequence of aging
Dzięgielewska-Gęsiak, S., Stołtny, D., Brożek, A., Muc‐Wierzgoń, M., & Wysocka, E. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220929621 · Cited by 21
Wang, M., Lin, W., Liu, H., Qian, Z. M., Chen, J., Rao, M., Zhou, Q., Zhuang, Z., Luo, L., Fang, Y., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112327 · Cited by 28
Macronutrient Intake and Insulin Resistance in 5665 Randomly Selected, Non-Diabetic U.S. Adults
Tucker, L. A. (2022) · Nutrients · doi:10.3390/nu14050918 · Cited by 23
Effoe, V. S., Wagenknecht, L. E., Echouffo-Tcheugui, J. B., Chen, H., Joseph, J. J., Kalyani, R. R., Bell, R. A., Wu, W.-C. H., Casanova, R., & Bertoni, A. G. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004229 · Cited by 20
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease
Djupsjö, C., Kuhl, J., Andersson, T., Lundbäck, M., Holzmann, M. J., & Nyström, T. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01699-y · Cited by 24
“Even though stress induced hyperglycemia has been suggested an essential survival response, elevated blood glucose levels in patients in an acute situation should raise concern and always be followed-up and treated to combat cardiovascular complications [42, 43].”
BackgroundCoello, S. D., Carrillo-Fernández, L., Hernández, J. G., Abad, M. M., Álamo, C. B., García-Dopico, J. A., Aguirre‐Jaime, A., & de León, A. C. (2020) · Nutrients · doi:10.3390/nu12041149 · Cited by 23
“Some studies have established a direct relationship between insulin resistance (IR) and both of these diseases [2,3].”
BackgroundFaghihi‐Kashani, S., Bonnet, F., Hafezi‐Nejad, N., Heidari, B., Nargesi, A. A., Sheikhbahaei, S., Ebadi, M., & Esteghamati, A. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.10.001 · Cited by 17
New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on Epigenetics
Ambrosini, S., Mohammed, S. A., Lüscher, T. F., Costantino, S., & Paneni, F. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00400-2 · Cited by 20
Costa, Y. C., Mauro, V. M., Fairman, E. B., Charask, A. A., Olguín, L., Cáceres, L., & Barrero, C. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101112 · Cited by 20
the ANRS CO13 HEPAVIH Study Group, Santos, M. É., Protopopescu, C., Sogni, P., Yaya, I., Piroth, L., Bailly, F., Marcellin, F., Esterle, L., Wittkop, L., et al. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02585-7 · Cited by 23
Hao, C., Lei, Z., Zhang, J., Hu, Q., Guo, F., Mo, Z., Huang, B., & Liu, C. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04529-7 · Cited by 24
Chevli, P. A., Mehta, A., Allison, M., Ding, J., Nasir, K., Blaha, M. J., Blankstein, R., Talegawkar, S. A., Kanaya, A. M., Shapiro, M. D., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac102 · Cited by 19
“We investigated the following as sensitivity analysis: (1) the association of CVH categories with subcutaneous fat adjusting for visceral fat; (2) the association of ectopic fat measures with the SPISE index; (3) heterogeneity in the associations by diabetes status; and (4) the association of ectopic fat measures with…”
MethodShi, Z., Gao, F., Liu, W., & He, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.869272 · Cited by 23
Cassano, V., Armentaro, G., Magurno, M., Aiello, V., Borrello, F., Miceli, S., Maio, R., Perticone, M., Marra, A. M., Cittadini, A., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1069828 · Cited by 21
“This is clinically relevant because HOMA index is more strongly associated with CVD than glucose or insulin concentration, in non-diabetic patients (Gast et al., 2012).”
BackgroundDoctors’ views and strategies to improve patients’ adherence to medication
Yfantopoulos, J., Protopapa, M., Chantzaras, A. E., & Yfantopoulos, P. (2021) · HORMONES · doi:10.1007/s42000-021-00294-2 · Cited by 18
zhai, G., Zhang, B., wang, J., Liu, Y., & Zhou, Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308263 · Cited by 19
Larsson, J., Auscher, S., Shamoun, A., Pararajasingam, G., Heinsen, L. J., Andersen, T. R., Lindholt, J. S., Diederichsen, A. C. P., Lambrechtsen, J., & Egstrup, K. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117328 · Cited by 20
FízeI'ová, M., Cederberg, H., Stančáková, A., Jauhiainen, R., Vangipurapu, J., Kuusisto, J., & Laakso, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109772 · Cited by 18
“Elevated fasting insulin concentrations reflect IR [16] and are associated with increased risk of CVD events [5,17,18].”
BackgroundThe effect of overweight/obesity on diastolic function in children and adolescents: A meta‐analysis
Burden, S. J., Weedon, B. D., Whaymand, L., Rademaker, J., Dawes, H., & Jones, A. (2021) · Clinical Obesity · doi:10.1111/cob.12476 · Cited by 19
Ghoreishian, H., Tohidi, M., Derakhshan, A., Hajsheikholeslami, F., Azizi, F., Kazempour‐Ardebili, S., & Hadaegh, F. (2015) · Diabetic Medicine · doi:10.1111/dme.12733 · Cited by 17
Cho, Y. K., Kim, H. S., Park, J., Lee, W. J., Kim, Y., & Jung, C. H. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21086 · Cited by 19
Sun, Y., Li, W., Hou, X., Wang, C., Li, C., Zhang, X., Yang, W., Ma, Z., Wang, W., Ning, G., et al. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140030 · Cited by 16
Qiu, J., Li, J., Xu, S. M., Zeng, H., Zhang, Y., Yang, S., Fang, L., Huang, J., Zhou, H., Feng, J., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02674-z · Cited by 19
“Subgroup analyses stratified by sex and median age (cutoff: 50 years) revealed distinct patterns in the mediation effects of TyG-related indices on cardiovascular health (CVH) and mortality (eFigure 8–9).”
Abuduaini, B., Yang, L., Jiamali, N., Seyiti, Z., Shan, X., & Gao, X.-M. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s408766 · Cited by 15
Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study
Roa‐Díaz, Z. M., Wehrli, F., Lambrinoudaki, I. V., Gebhard, C., Baumgärtner, I., Marques-Vidal, P. M., Bano, A., Raguindin, P. F., & Muka, T. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002184 · Cited by 15
Marra, A., Bondesan, A., Caroli, D., & Sartório, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072120 · Cited by 19
“…study aimed to assess the diagnostic value of CBC-derived inflammation indexes (MHR, LHR, NHR, and SIRI) in detecting the MetS presence in adolescents with severe obesity and their association with well-known cardiovascular risk biomarkers (HOMA-IR [46,47], non-HDL-C [48] and TG/HDL-C [49]).”
BackgroundTriglyceride‐Glucose Index Association With Severity of Coronary Artery Disease
Soflaei, S. S., Sangani, P. S., Fallahi, Z., Imanparast, F., Marousi, M., Tajfard, M., Ferns, G. A., Moohebati, M., & Ghayour‐Mobarhan, M. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70025 · Cited by 18
“In a systematic review and meta-analysis that comprised 516,325 subjects, IR was evaluated using the HOMA index, and the results demonstrated that IR may emerge as a promising independent factor in predicting CAD [38].”
Kruszelnicka, O., Surdacki, A., & Golay, A. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-145 · Cited by 14
Brener, M. I., Post, W. S., Haberlen, S., Zhang, L., Palella, F. J., Jacobson, L. P., Dobs, A. S., George, R. T., Witt, M. D., Budoff, M. J., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.037 · Cited by 14
Ayan, E. B., & DeMirci, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 15
Jung, C., Rhee, E., Kim, K.-J., Kim, B., Park, S. E., Chang, Y., Ryu, S., Park, C., Mok, J., Oh, K.-W., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.011 · Cited by 16
“Also, recent meta-analyses have shown that elevated insulin resistance in nondiabetic subjects was associated with an increased CVD risk (6).”
Ikezaki, H., Ai, M., Schaefer, E. J., Otokozawa, S., Asztalos, B. F., Nakajima, K., Zhou, Y., Liu, C., Jacques, P. F., Cupples, L. A., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.014 · Cited by 15
Mao, Q., Liu, N., Xiong, T., Wang, X., Tian, X., & Kong, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1562135 · Cited by 15
RetractedOtsuka, K., Yamaura, H., Shimada, K., Sugiyama, T., Hojo, K., Ishikawa, H., Kono, Y., Kasayuki, N., & Fukuda, D. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200250 · Cited by 15
“In addition, meta-analyses have consistently found that the homeostatic model assessment for insulin resistance (HOMA-IR) is associated with an increased risk of incident cardiovascular disease and all-cause mortality in individuals without DM [7,8].”
BackgroundInsulin resistance, metabolic syndrome, and lipids in African women
Young, E., Okafor, C., Iroezindu, M., & Agbalu, I. (2016) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.183242 · Cited by 16
Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients
Muendlein, A., Brandtner, E. M., Leiherer, A., Geiger, K. D., Heinzle, C. F., Gaenger, S., Fraunberger, P., MADER, A., Saely, C. H., & Drexel, H. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.02.015 · Cited by 13
Gala, T. D. L. H., Herder, C., Rutters, F., Carstensen‐Kirberg, M., Huth, C., Stehouwer, C. D. A., Nijpels, G., Schalkwijk, C. G., Flyvbjerg, A., Franks, P. W., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3063 · Cited by 13
Barbarroja, N., Medina, C. L., Escudero‐Contreras, A., & de la Rosa, I. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1459185 · Cited by 16
Yang, Y., Zhang, Y., Wang, J., Ning, X., Zhang, Y., Zhao, T., Zhong, Y., Liu, Z., Xia, L., Li, W., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.656230 · Cited by 13
He, Y., He, J., Chen, D., & Xiao, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1699985 · Cited by 17
Genetic variation in 9p21, dietary patterns, and insulin sensitivity
Mahdavi, S., Jenkins, D. J. A., & El‐Sohemy, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.988873 · Cited by 12
“Insulin resistance (IR) and glucose intolerance in young adults are risk factors for cardiovascular disease (CVD) in middle and late adulthood, even in those without diabetes (Gast et al., 2012).”
BackgroundLiu, C., Zhao, Q., Zhao, Z., Ma, X., Xia, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1033354 · Cited by 11
Janssen, L., Hopman, M. T. E., Swaans, G. J. A., Allard, N. A. E., Boss, M., Lobeek, D., Gotthardt, M., Schirris, T. J. J., Blijlevens, N. M. A., & Timmers, S. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00163.2022 · Cited by 12
Zhao, H., Wang, Y., Wang, C., & Meng, Q.-K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1323615 · Cited by 11
“The TyG index is considered a residual risk factor for CVD.”
BackgroundInfluentialThe impact of triglyceride-glucose index on the prognosis of post-PCI patients–a meta-analysis
Wang, Y., Kong, X.-H., Tao, H., & Tao, L. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1396865 · Cited by 14
“This condition also impacts individuals without diabetes (3, 4).”
BackgroundPsychosocial Disadvantage During Childhood and Midlife Health: NIMHD Social Epigenomics Program
Brown, R. L., Alegria, K. E., Hamlat, E. J., Tomiyama, A. J., Laraia, B. A., Crimmins, E. M., Moffitt, T. E., & Epel, E. S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.21841 · Cited by 13
Armato, J., DeFronzo, R. A., Abdul‐Ghani, M. A., & Ruby, R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae540 · Cited by 13
Liu, C., Liang, D., Xiang, G., Zhao, X., Xiao, K., & Xie, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-86612-9 · Cited by 12
Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals
Nakamura, S., Mori, K., Okuma, H., Sekine, T., Miyazaki, A., & Tsuchiya, K. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/1479164121989281 · Cited by 14
Fahmy, A. M., shall, N. E., Kabbash, I., Ahwal, L. E., & Selim, A. A. E. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0012 · Cited by 12
Metadata
- Authors
- Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Gast, Karin B.
- Tjeerdema, Nathanja
- Stijnen, Theo
- Smit, Johannes W. A.
- Dekkers, Olaf M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-28
- Volume
- 7
- Issue
- 12
- Pages
- e52036
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3532497
- OpenAlex
- W2039758398
- Cited by
- 403
- References
- 33
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 60 · 2023: 50 · 2022: 52 · 2021: 40 · 2020: 35 · 2019: 26 · 2018: 17 · 2017: 15 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Universiteit Leiden
- Leids Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, HOMA-IR, fasting blood glucose, fasting insulin, incident cardiovascular disease, coronary artery disease, stroke, cardiovascular risk prediction, non-diabetic adults, risk stratification model, risk reclassification, risk prediction thresholds
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.